key: cord-1014845-glhwhvcf
authors: Gaudreault, Natasha N.; Carossino, Mariano; Morozov, Igor; Trujillo, Jessie D.; Meekins, David A.; Madden, Daniel W.; Cool, Konner; Artiaga, Bianca Libanori; McDowell, Chester; Bold, Dashzeveg; Balaraman, Velmurugan; Kwon, Taeyong; Ma, Wenjun; Henningson, Jamie; Wilson, Dennis W.; Wilson, William C.; Balasuriya, Udeni B. R.; García-Sastre, Adolfo; Richt, Juergen A.
title: Experimental re-infected cats do not transmit SARS-CoV-2
date: 2021-01-19
journal: bioRxiv
DOI: 10.1101/2021.01.18.427182
sha: 78fdf479b9f08af96f9f89051ffa4edbb43f03cb
doc_id: 1014845
cord_uid: glhwhvcf

SARS-CoV-2 is the causative agent of COVID-19 and responsible for the current global pandemic. We and others have previously demonstrated that cats are susceptible to SARS-CoV-2 infection and can efficiently transmit the virus to naïve cats. Here, we address whether cats previously exposed to SARS-CoV-2 can be re-infected with SARS-CoV-2. In two independent studies, SARS-CoV-2-infected cats were re-challenged with SARS-CoV-2 at 21 days post primary challenge (DPC) and necropsies performed at 4, 7 and 14 days post-secondary challenge (DP2C). Sentinels were co-mingled with the re-challenged cats at 1 DP2C. Clinical signs were recorded, and nasal, oropharyngeal, and rectal swabs, blood, and serum were collected and tissues examined for histologic lesions. Viral RNA was transiently shed via the nasal, oropharyngeal and rectal cavities of the re-challenged cats. Viral RNA was detected in various tissues of re-challenged cats euthanized at 4 DP2C, mainly in the upper respiratory tract and lymphoid tissues, but less frequently and at lower levels in the lower respiratory tract when compared to primary SARS-CoV-2 challenged cats at 4 DPC. Histologic lesions that characterized primary SARS-CoV-2 infected cats at 4 DPC were absent in the re-challenged cats. Naïve sentinels co-housed with the re-challenged cats did not shed virus or seroconvert. Together, our results indicate that cats previously infected with SARS-CoV-2 can be experimentally re-infected with SARS-CoV-2; however, the levels of virus shed was insufficient for transmission to co-housed naïve sentinels. We conclude that SARS-CoV-2 infection in cats induces immune responses that provide partial, non-sterilizing immune protection against reinfection.

the remaining 3 principals and the 2 sentinels were re-challenged with SARS-CoV-2 using same 115 dose and route as in the primary challenge. At 1 DP2C, 2 new naïve sentinel cats were 116 introduced. Two re-challenged animals each were euthanized and postmortem examinations 117 performed at 4 and 7 DP2C, respectively. The remaining re-challenged cat and the 2 sentinels 118 were euthanized and postmortem examinations performed at 14 DP2C. 119 Clinical evaluations and sample collection 120 Cats were observed daily for clinical signs, as described previously (12) . Weights of all 121 cats were recorded on bleed days. Blood and serum were collected from all primary inoculated 122 and sentinel cats at 0, 1, 3, 4, 7, 14 and 21 DPC, and the re-infected and sentinels at 0, 1, 3, 4, 7, 169 RNAscope® ISH was performed as previously described (12) using an anti-sense probe Two independent studies were conducted by inoculating 3 and 5 principal cats with 203 SARS-CoV-2 in the first and second studies, respectively, and introducing 2 sentinel contact cats 204 at 1 DP2C in the second study (12; Figure 1 ). Similar to our previous study (12), primary 205 SARS-CoV-2 challenged cats shed virus from nasal, oral and rectal cavities and efficiently 206 transmitted the virus to the naïve sentinels (Figure 2a-c) . Viral RNA was found in multiple 207 tissues of the 2 principal infected cats euthanized at 4 DPC, including the URT, LRT, GIT, 208 lymphatic organs, heart and olfactory bulb (Figure 3) . Histologic lesions were restricted to the 209 upper respiratory tract and bronchial tree as previously described (12). Within the nasal cavity, (Tables 2 and 3) . 228 At this timepoint, the intense neutrophilic rhinitis noted at 4 DPC was replaced by multifocal 238 shedding 239 At 21 DPC/0 DP2C, 3 cats from the first study and 5 cats of the second study were re-240 challenged with SARS-CoV-2 (Figure 1 ). In the first study, viral shedding was detected from 241 nasal swabs at 1 DP2C and from rectal swabs at 1 to 4 DP2C, but not from oropharyngeal swabs 242 of the 3 re-challenged cats (Figure 2d ). In contrast, re-challenged cats from the second study 243 shed viral RNA from the nasal cavity at 1 through 4 DP2C and from the oropharyngeal cavity at 244 1 through 11 DP2C; however, no viral RNA was detected from rectal swabs after re-challenge in 245 study 2 (Figure 2a-c) . 246 In addition, viral RNA was detected in the nasal wash, URT and GIT tissues of re- nasal, oropharyngeal and rectal cavities was observed in these animals (Figure 2a-c) and no viral 292 RNA was detected in tissues from either of the sentinel cats examined at 14 DP2C (Figure 3) . 293 Furthermore, the naïve sentinel cats co-housed with the re-infected cats for the 13 days after re-294 challenge did not seroconvert (Tables 2 and 3) . Histologic evaluation of the nasal cavity Our results indicate that a primary SARS-CoV-2 infection was mostly resolved within 21 314 DPC. At 21 DPC, viral RNA shedding had subsided in the nasal and rectal cavities (Figure 2) , 315 no viral RNA or antigen were detected in the upper and lower respiratory tract with the exception 316 of nasal turbinate and nasopharynx homogenates (Figure 3 and 4) , and the histologic changes Other SARS-CoV-2 re-infection studies in cats, ferrets and rhesus macaques also showed 363 at least partial to full protection from re-exposure at 4 weeks after primary challenge (26-28). In a study by Bosco-Lauth and colleagues (2020), 3 adult cats 5-8 years of age were experimentally 365 infected with SARS-CoV-2 and re-challenged 28 days later. In that study, no nasal or oral 366 shedding of virus was observed during the 7 days after re-challenge and it was concluded that the 367 animals were resistant to SARS-CoV-2 re-infection (15). In our studies, we also did not detect 

A pneumonia outbreak associated with 436 a new coronavirus of probable bat origin

Detection of SARS-CoV-2 in a 438 cat owned by a COVID-19-affected patient in Spain

A household case evidences 441 shorter shedding of SARS-CoV-2 in naturally

Respiratory disease in 444 cats associated with human-to-cat transmission of SARS-CoV-2 in the UK

SARS-CoV-2 in pets living with COVID-19 owners diagnosed during the COVID-19 lockdown in 448

A case of an asymptomatic cat with SARS-CoV-2 in Europe

CoV-2

High prevalence of SARS

SARS-CoV-2 infection in farmed minks, the Netherlands

CoV-2 Transmission between Mink (Neovison vison) and Humans, Denmark. Emerg Infect Dis

Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans

A Critical Needs Assessment for Research in Companion 463

Animals and Livestock Following the Pandemic of COVID-19 in Humans. Vector Borne Zoonotic 464

infection, disease and transmission in domestic cats

Susceptibility of ferrets, cats, dogs, and 468 other domesticated animals to SARS-coronavirus 2

Transmission of SARS-CoV-2 470 in Domestic Cats

Experimental 472 infection of domestic dogs and cats with SARS-CoV-2: Pathogenesis, transmission, and response 473 to reexposure in cats

A serological survey of SARS-CoV-2 in cat 475 in Wuhan

 407 We thank the staff of KSU Biosecurity Research Institute, the histological laboratory at the Kansas